Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death
1998 ◽
Vol 24
(5)
◽
pp. 389-396
◽
2004 ◽
Vol 321
(3)
◽
pp. 524-530
◽
2001 ◽
Vol 51
(3)
◽
pp. 775-784
◽
2019 ◽
Vol 1863
(5)
◽
pp. 903-916
◽
2016 ◽
Vol 49
(1)
◽
pp. 173-180
◽
2008 ◽
Vol 2008
◽
pp. 231-233
2009 ◽
Vol 11
(8)
◽
pp. 1208-1218
◽